Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia — Stella

Recruiting

Back to Aphasia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Pennsylvania, Philadelphia, Pennsylvania

Key details

Phase

Safety & dosing

Sponsor

University of Pennsylvania

Collaborators

Temple University, National Institute on Deafness and Other Communication Disorders (NIDCD)

Enrollment target

~24 participants

Started

February 2025

Primary completion

August 2026

Age range

40 Years – 85 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov